Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Diquafosol
2. Ins 365
3. Ins-365
4. Ins365
1. 211427-08-6
2. Ins365
3. Up4u
4. Diquafosol Sodium
5. Kpy-998
6. De-089
7. X8t9sbh9ll
8. Diquafosol Tetrasodium Salt
9. Diquafosol Tetrasodium [usan]
10. Diquafosol Sodium (jan)
11. Tetrasodium;[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] Phosphate
12. Diquafosol Tetrasodium (usan)
13. Uridine(5')tetraphospho(5')uridine Tetrasodium Salt
14. Diquafosol (tetrasodium)
15. Diquafosol Sodium [jan]
16. Chembl1767408
17. Ins-365
18. Prolacria
19. Diquas
20. Unii-x8t9sbh9ll
21. Ins365 Ophthalmic Solution
22. U2p4
23. Ex-a6122
24. Diquafosol Tetrasodium [mart.]
25. Diquafosol Tetrasodium [who-dd]
26. Diquafosol Tetrasodium Salt [mi]
27. Ac-36639
28. D03864
29. A900791
30. P1,p4-diuridine 5'-tetraphosphate Tetrasodium Salt
31. Q27293698
32. Uridine 5'-(pentahydrogen Tetraphosphate), P'''-5'ester With Uridine, Tetrasodium Salt
33. Uridine, 5'-(pentahydrogen Tetraphosphate), P'''-5'-ester With Uridine, Tetrasodium Salt
34. Uridine, 5'-(pentahydrogen Tetraphosphate), P''' ->5'-ester With Uridine, Tetrasodium Salt
| Molecular Weight | 878.2 g/mol |
|---|---|
| Molecular Formula | C18H22N4Na4O23P4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 23 |
| Rotatable Bond Count | 14 |
| Exact Mass | 877.9216081 g/mol |
| Monoisotopic Mass | 877.9216081 g/mol |
| Topological Polar Surface Area | 405 Ų |
| Heavy Atom Count | 53 |
| Formal Charge | 0 |
| Complexity | 1460 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Diquafosol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diquafosol, including repackagers and relabelers. The FDA regulates Diquafosol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diquafosol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diquafosol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diquafosol supplier is an individual or a company that provides Diquafosol active pharmaceutical ingredient (API) or Diquafosol finished formulations upon request. The Diquafosol suppliers may include Diquafosol API manufacturers, exporters, distributors and traders.
click here to find a list of Diquafosol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diquafosol DMF (Drug Master File) is a document detailing the whole manufacturing process of Diquafosol active pharmaceutical ingredient (API) in detail. Different forms of Diquafosol DMFs exist exist since differing nations have different regulations, such as Diquafosol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diquafosol DMF submitted to regulatory agencies in the US is known as a USDMF. Diquafosol USDMF includes data on Diquafosol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diquafosol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diquafosol suppliers with USDMF on PharmaCompass.
Diquafosol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diquafosol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diquafosol GMP manufacturer or Diquafosol GMP API supplier for your needs.
A Diquafosol CoA (Certificate of Analysis) is a formal document that attests to Diquafosol's compliance with Diquafosol specifications and serves as a tool for batch-level quality control.
Diquafosol CoA mostly includes findings from lab analyses of a specific batch. For each Diquafosol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diquafosol may be tested according to a variety of international standards, such as European Pharmacopoeia (Diquafosol EP), Diquafosol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diquafosol USP).
LOOKING FOR A SUPPLIER?
